WO2022206083A1 - Miniature in-vivo robot device, and optimal treatment regulation and control system and method - Google Patents
Miniature in-vivo robot device, and optimal treatment regulation and control system and method Download PDFInfo
- Publication number
- WO2022206083A1 WO2022206083A1 PCT/CN2022/000044 CN2022000044W WO2022206083A1 WO 2022206083 A1 WO2022206083 A1 WO 2022206083A1 CN 2022000044 W CN2022000044 W CN 2022000044W WO 2022206083 A1 WO2022206083 A1 WO 2022206083A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vivo
- micro
- treatment
- drug
- robot
- Prior art date
Links
- 238000001727 in vivo Methods 0.000 title claims abstract description 166
- 238000000034 method Methods 0.000 title claims abstract description 97
- 238000011369 optimal treatment Methods 0.000 title description 2
- 238000011282 treatment Methods 0.000 claims abstract description 131
- 238000003384 imaging method Methods 0.000 claims abstract description 74
- 238000012377 drug delivery Methods 0.000 claims abstract description 64
- 238000000338 in vitro Methods 0.000 claims abstract description 64
- 201000010099 disease Diseases 0.000 claims abstract description 58
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 58
- 210000000056 organ Anatomy 0.000 claims abstract description 57
- 230000000694 effects Effects 0.000 claims abstract description 32
- 238000012544 monitoring process Methods 0.000 claims abstract description 25
- 238000012545 processing Methods 0.000 claims abstract description 6
- 210000000436 anus Anatomy 0.000 claims abstract description 4
- 210000000214 mouth Anatomy 0.000 claims abstract description 4
- 210000003928 nasal cavity Anatomy 0.000 claims abstract description 4
- 210000001215 vagina Anatomy 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 134
- 229940079593 drug Drugs 0.000 claims description 128
- 206010028980 Neoplasm Diseases 0.000 claims description 69
- 238000001356 surgical procedure Methods 0.000 claims description 31
- 230000006378 damage Effects 0.000 claims description 29
- 238000007689 inspection Methods 0.000 claims description 23
- 238000001647 drug administration Methods 0.000 claims description 18
- 238000005457 optimization Methods 0.000 claims description 17
- 238000002626 targeted therapy Methods 0.000 claims description 17
- 238000004364 calculation method Methods 0.000 claims description 15
- 238000002513 implantation Methods 0.000 claims description 15
- 238000009297 electrocoagulation Methods 0.000 claims description 14
- 230000000007 visual effect Effects 0.000 claims description 13
- 230000009977 dual effect Effects 0.000 claims description 11
- 238000013178 mathematical model Methods 0.000 claims description 11
- 238000010899 nucleation Methods 0.000 claims description 11
- 229940121896 radiopharmaceutical Drugs 0.000 claims description 11
- 239000012217 radiopharmaceutical Substances 0.000 claims description 11
- 230000002799 radiopharmaceutical effect Effects 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 10
- 230000002285 radioactive effect Effects 0.000 claims description 10
- 238000001959 radiotherapy Methods 0.000 claims description 10
- 230000000711 cancerogenic effect Effects 0.000 claims description 9
- 231100000315 carcinogenic Toxicity 0.000 claims description 9
- 238000003698 laser cutting Methods 0.000 claims description 9
- 238000002560 therapeutic procedure Methods 0.000 claims description 9
- 210000004881 tumor cell Anatomy 0.000 claims description 9
- 206010061218 Inflammation Diseases 0.000 claims description 8
- 230000010391 action planning Effects 0.000 claims description 8
- 238000013528 artificial neural network Methods 0.000 claims description 8
- 208000031513 cyst Diseases 0.000 claims description 8
- 230000004054 inflammatory process Effects 0.000 claims description 8
- 210000001835 viscera Anatomy 0.000 claims description 8
- 206010011732 Cyst Diseases 0.000 claims description 6
- 238000011503 in vivo imaging Methods 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 238000010317 ablation therapy Methods 0.000 claims description 4
- 229940044683 chemotherapy drug Drugs 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000003068 static effect Effects 0.000 claims description 4
- 230000009182 swimming Effects 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 210000000613 ear canal Anatomy 0.000 claims description 3
- 238000012549 training Methods 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 238000011426 transformation method Methods 0.000 claims description 3
- 238000011298 ablation treatment Methods 0.000 claims description 2
- 238000013170 computed tomography imaging Methods 0.000 claims description 2
- 238000002651 drug therapy Methods 0.000 claims description 2
- 230000002068 genetic effect Effects 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 238000002922 simulated annealing Methods 0.000 claims description 2
- 230000008733 trauma Effects 0.000 claims description 2
- 238000012285 ultrasound imaging Methods 0.000 claims description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 238000001839 endoscopy Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000013473 artificial intelligence Methods 0.000 abstract description 3
- 238000005286 illumination Methods 0.000 abstract description 2
- 238000011002 quantification Methods 0.000 description 5
- 238000002679 ablation Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002406 microsurgery Methods 0.000 description 2
- 230000008816 organ damage Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00131—Accessories for endoscopes
- A61B1/00133—Drive units for endoscopic tools inserted through or with the endoscope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00147—Holding or positioning arrangements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00147—Holding or positioning arrangements
- A61B1/00158—Holding or positioning arrangements using magnetic field
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/045—Control thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/06—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor with illuminating arrangements
- A61B1/0661—Endoscope light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/007—Injectors for solid bodies, e.g. suppositories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
- A61N5/1031—Treatment planning systems using a specific method of dose optimization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00345—Micromachines, nanomachines, microsystems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
- A61B2034/2051—Electromagnetic tracking systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/587—Lighting arrangements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1021—Radioactive fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1024—Seeds
Definitions
- the invention belongs to the technical field of artificial intelligence robot health medical equipment, and relates to micro-robot technology, artificial intelligence image intelligent recognition, remote control, and optimization related theories and technical fields.
- the in-vivo vision device and the in-vitro imaging device realize high-precision acquisition of in-vivo images, intelligently identify dual images, and assist in identifying damaged tissues, tumors and locating their positions in the body. Double-accurate identification of human organs, damaged tissues, high-precision identification of normal areas and damaged areas.
- Multi-sensing module for real-time monitoring of in vivo body environment.
- Micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize micro cutting suture, puncture, cautery, laser cutting, targeted therapy.
- the multi-objective optimization of comprehensive indicators can be achieved, the drug and its quantification can be controlled, and the optimal regulation of the disease in vivo can be achieved.
- the purpose of the present invention is to overcome the above-mentioned shortcomings and deficiencies of the prior art, and to provide a micro-robot device for use in the body, which can be non-invasively delivered into the body through magnetic guidance, thereby reducing the risk of extracorporeal surgery.
- Dual imaging devices intelligently identify diseases and reduce human errors in diagnosis and treatment. Sensors collect data in real time, optimize drug delivery, monitor in vivo data in real time, track the effect of in vivo treatment in real time, dynamically adjust and optimize in vivo drugs, drug dosage, precise drug administration, and efficiently solve problems such as tumors and tissue damage.
- the invention provides a remote control for administrators, which can accurately locate damaged tissue through in-vivo imaging of a camera and an in-vitro imaging guide device, accurately divide the damaged tissue area and the normal tissue area, and implement treatment according to the degree of damage.
- the invention also provides A high-precision organ, double-accurate positioning of damaged tissue, and double-accurate identification method.
- the present invention also provides a method for determining and quantifying a drug using an optimized method, an optimized dosing planning method for radiopharmaceuticals, realizing multi-objective optimization of comprehensive indicators, regulating drugs and their quantification, and realizing optimal regulation of in vivo conditions. Also provided is a high-precision positioning, remote-controlled non-invasive in vivo surgical method and a remote and autonomous drug delivery method.
- an in-vivo micro-robot device an optimized treatment regulation system and method, is characterized in that, an in-vivo micro-robot device comprises:
- the in vivo micro-robot device includes: visual recognition module, multi-sensing module, lighting device, in-vivo walking drive device, puncture device, retractable puncture needle, pressure device, surgical inspection processing device, ultrasonic microelectrode array, micro ultrasonic probe device, particle implant Insertion device, stent, soft stent, fixation device, precise drug delivery device.
- the in vitro imaging device is used for in vitro imaging, including one of various imaging methods such as ultrasound imaging, CT imaging, and X-ray imaging.
- the miniature camera and visual recognition module in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
- the multi-sensing module includes: one or more of a variety of sensors such as miniature biosensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
- the driving device is used to drive the robot to swim in a non-damaged, speed-controlled and directional manner in the body.
- the guiding, positioning, and moving device is connected with the in vitro imaging device, and the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in-vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in-vivo micro-robot to locate the damaged tissue and tumor in the body.
- Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices.
- Soft stent, fixation device used for swimming in the body, temporary stop, damaged tissue, and fixation of tumor location during surgical treatment.
- Retractable in-vivo inspection and surgical treatment devices including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device.
- micro forceps including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device.
- Retractable and precise drug delivery device used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
- the body is moved and positioned by electromagnetic, radio frequency, magnetic and other guiding devices, reducing the high risk of external surgical trauma, and achieving basic non-invasive, internal inspection, surgery, and efficient realization In vivo real-time monitoring, optimal control of in vivo conditions.
- Dual-accurate imaging methods using the in-vivo camera and visual recognition module of the miniature camera to work together with the in-vitro imaging device, high-precision acquisition, assisting in identifying images of organs, damaged tissues, tumors, etc., and accurately identifying damaged tissues and normal tissue areas.
- the in-vivo camera and visual recognition module are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
- the visual recognition module includes: one or more of in vivo imaging devices such as a micro endoscope and a micro microscope, and a 3D imaging system cooperates with an in vitro imaging guide device to collect and intelligently identify images of various diseases in the body.
- the driving device drives the robot to swim without damage in the body, with controllable speed and direction.
- Use soft stents and fixation devices to temporarily fix, assist in-vivo robots to perform surgery, check damaged tissue, etc. to complete in-vivo treatment.
- the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in vivo micro-robot to locate the damaged tissue and tumor in the body.
- driving device used to drive the micro robot to move, walk and swim in the body.
- the driving device includes one of current driving, electromagnetic driving and magnetic driving.
- Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Conduct in-vivo communication, guide in-vivo robot positioning, and move devices. Soft stent, fixation device, used for in vivo tissue examination, damaged tissue, fixation during surgical treatment of tumor location.
- the multi-sensing module monitors the in vivo environment in real time.
- Multi-sensing includes: one or more of various sensors such as micro bio-sensing, micro-medical sensing, and comprehensive gene sensing, which are used to collect sensor information in vivo and monitor the in-vivo environment in real time.
- the in vivo environment includes: the in vivo immune environment and the tumor treatment microenvironment, and the in vivo environment during monitoring.
- Surgical inspection and processing devices including: one or more of micro forceps, micro forceps, puncture retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, and laser devices.
- puncture surgical operation.
- the damaged tissue can be accurately positioned, and the damaged tissue area and the normal tissue area can be accurately divided.
- the miniature tweezers built into the in vivo micro-robot device are remotely controlled, and the puncture is retractable. Needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device realize cutting, suturing, puncturing, cauterization, laser cutting, targeted therapy.
- the region realizes the smallest side effects of the drug administration and the optimized drug administration effect.
- Retractable and precise drug delivery device used to locate damaged tissue, tumor location, calculate damaged tissue, tumor size, degree of damage, precise drug delivery, drug delivery device, used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cells Targeted drug delivery, radiotherapy, radioactive seed implantation and other precise drug delivery treatments.
- Organs double accurate positioning of damaged tissues, double accurate identification methods.
- the in-vivo vision device and the in-vitro imaging device can accurately identify human organs, damaged tissues, and divide the normal area and the damaged area with high precision.
- the method of robot double image matching, positioning, and accurately dividing the diseased position of damaged tissue and normal tissue including the following steps:
- the micro-robot publishes the position area and coordinate boundary of the organ in the image under the in vivo microscope, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates.
- the in vitro imaging system module publishes the position area of the organ and its coordinate boundary of the in vitro imaging image, and the robot main system and the intelligent identification module subscribe to the published image and position coordinates.
- the intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
- Optimal methods are used to regulate drugs and treatment methods. The specific steps of control are as follows:
- Drug regulation includes: drug selection, drug dosage, and drug cycle.
- Modulated treatment methods include: internal surgery, precision medicine with common drugs, targeted therapy, radiation therapy, radioactive seed implantation, and ablation therapy. Set the comprehensive indicators of multiple treatments as multi-objectives, and optimize the control treatment plan.
- the optimization methods include: genetic calculation method and its improvement method, tabu search calculation method and its improvement method, simulated annealing calculation method and its improvement method, ant colony calculation method and its improvement method, particle beam optimization calculation method One or more of methods for improving and improving methods thereof, neural network computing methods and methods for improving them, and methods for evolution and methods for improving them.
- Monitored indicators of the internal immune environment of the body, and indicators of the tumor treatment microenvironment are constant.
- the optimal tumor treatment microenvironment the absolute value of the difference between the monitoring index and the standard index * the sum of the weights.
- the main treatment methods in vivo surgery, precision medicine treatment, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy, etc.
- main drug main drug (main drug m m ⁇ 1, 2, ....M ⁇ )
- Monitoring indicators monitor e e ⁇ 1, 2, ....E ⁇ , monitoring real-time indicators monitor e-realtime , monitoring indicators standard monitor e-std side effects monitoring indicators monitor sub-b b ⁇ 1, 2, ... .B ⁇ .
- the number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
- Constraints include:
- Multi-target includes:
- the body's internal immune environment is optimal,
- the drug is optimally regulated, the amount of the drug, the precise positioning of the carcinogenic site, the specific tumor cell, and the delivery. Drugs to achieve optimal regulation of treatment.
- a high-precision positioning, remote-controlled non-invasive in-vivo surgical method and a remote and autonomous drug administration method comprises the following steps:
- the main control system publishes disease images and location information of damaged tissues.
- the robot driving module, the radio frequency receiver or the electromagnetic guidance autonomous positioning mobile module subscribes to the location message.
- the radio frequency receiver or the electromagnetic guided magnetic guided autonomous positioning and moving module guides the internal magnetic device to drive the micro robot to swim and move to the position of the damaged tissue.
- the double-precision positioning and double-precision identification method of damaged tissue High-precision division of normal areas and damaged areas.
- the action planning instruction message is released, the robot checks the surgical device, and the robot treatment device subscribes to the instruction message.
- the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
- step S6 the robot inspects the surgical device module, images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage.
- the doctor remotely controls the micro forceps, micro forceps, puncture and retractable needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, laser device and other surgical devices built into the micro robot in the body, inspecting damaged tissue and performing surgical operations , to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
- step S6 the robot treatment and drug administration action planning module images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area according to the degree of damage.
- the main control system publishes the returned drug delivery route and the position coordinates of each seeding point.
- the doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.
- the invention can solve the problem of remote control of the micro-robot through the micro-robot device, magnetically guided movement, intelligent identification of organs, diseases, and damaged tissues by means of dual visual recognition devices, locating their positions, and moving to their positions, using micro-surgical devices, laser emitting devices , radio frequency devices, ablation, treatment of diseases in vivo.
- a high-precision positioning, remote control non-invasive in-vivo surgical method and a remote and autonomous drug delivery method solve and effectively utilize the optimal drug delivery device, and achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
- the doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
- the present invention can monitor and regulate in vivo state in real time by optimizing the regulation system, so as to realize the optimal treatment in vivo.
- Fig. 1 is the schematic diagram of the micro-robot device module in the specification of the present application, and Fig. 1 is marked:
- 101-main control system 101-main control system; 102-multi-sensing module; 103-in vivo camera vision module, lighting module; 104-guidance module;
- 109-precise drug delivery module 110-in vitro imaging system; 111-remote control module;
- 201-vision device 202-camera; 203-in vivo guidance device; 204-miniature surgical device;
- 205-therapeutic device 206-multi-sensing; 207-drive device; 208-telescopic support, fixing device;
- 209-main control system 210-in vitro imaging system; 211-in vitro guidance device; 212 precise drug delivery device;
- the purpose of the present invention is to design a micro-robot device capable of remote control in vivo that can replace human work, realize real-time monitoring in vivo, non-invasive treatment, intelligent identification of organs, diseases, and damaged tissue images by dual-vision recognition device, and effectively improve the accuracy of surgery.
- the doctor remotely controls the built-in miniature forceps, miniature forceps, puncture and retractable needles, miniature electrocautery, miniature electrocoagulation device, miniature cautery device, radio frequency device, laser device and other surgical devices built in the micro-robot to check and perform surgical operations to achieve cutting Suture, puncture, cautery, laser cutting, targeted therapy.
- the dual-visual recognition device is used to intelligently identify organs, diseases, and damaged tissues.
- the micro-robot locates the damaged tissue in the body, and double-accurately divides the damaged tissue area and the normal tissue area, positioning, and moving.
- Remote control by administrators, non-invasive in-vivo surgery, high-precision positioning, remote control of in-vivo micro-robots Built-in micro forceps, micro forceps, puncture retractable needles, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, Laser devices and other surgical devices check and perform surgical operations to achieve cutting and suturing, puncture, cautery, laser cutting, and targeted therapy.
- Remote and autonomous drug delivery using the optimal drug delivery device to achieve treatment optimization by calculating the drug, drug dosage, and drug cycle.
- a micro-robot device includes:
- the in vivo micro-robot device includes: a visual recognition module 103, a multi-sensing module 102, a lighting device 103, an in-vivo walking driving device 106, a puncture device, a retractable puncture needle, a pressure device, a surgical inspection and processing device, a treatment device 108, a bracket, a soft bracket , the fixing device 107 , the precise dosing device 111 .
- the in-vitro imaging 110 a guiding device, is used for in-vitro imaging.
- the in-vitro imaging system guides the in-vivo micro-robot to position and move autonomously, assists in collecting in-vivo images, assists in identifying in-vivo damaged tissues and tumors, and guides the in-vivo micro-robots to locate in-vivo damaged tissues and tumors.
- the miniature camera and the visual recognition module 102 in the body are used to collect in-vivo images to assist in identifying damaged tissues and tumors in the body and locating their positions.
- the illuminating device 103 is used for in-vivo illumination, imaging inspection.
- the multi-sensing module 102 includes: one or more kinds of sensors such as micro-biological sensing and comprehensive gene sensing, and is used to collect sensor information in vivo.
- the driving device 106 is used to drive the micro robot to move in vivo.
- Ultrasound microelectrode array miniature ultrasound probe device, used for acquisition of ultrasound images.
- surgical treatment device 107 including: micro forceps, micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, one or more of laser devices, with For examination, puncture, surgical operation.
- Therapeutic device 108 is used to damage tissue into which the tumor drug is placed prior to implantation.
- the soft stent, the fixing device 105 is used for walking in the body, fixing damaged tissues, and fixing the tumor position during surgical treatment.
- the precise drug delivery device 111 is used to locate the damaged tissue and the position of the tumor, calculate the size of the damaged tissue, the tumor, and the degree of damage, accurately determine the drug, and administer the drug.
- the external imaging device 210 and the characteristic positions of human organs, medical images and microscopes, and the method for identifying internal organs under the endoscope 201 include the following steps:
- the eigenvalues of the human internal organ images corresponding to the external eigenvalues of the organs, the improved deep neural network method and the weight optimizer, through image training, can identify the human organ images under in vitro imaging and in vivo microscopes.
- the micro-robot publishes the location area and its coordinates of the organs in the images under the in vivo microscope, and uses the coordinate transformation method to establish the coordinate reference transformation of the dual images under the main control system of the robot, so as to realize the matching of the organs and their coordinate positions under the dual images of each organ.
- Input under the in vivo microscope under the in vitro imaging system to image damaged tissue inflammation, tumor, cyst and other disease models.
- the disease under the dual system image is identified, and the disease location area, size and return position coordinates are marked and drawn under the dual image.
- the intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
- the master control system publishes disease images, information on the location of damaged tissue.
- the robot driving module 207, radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to subscribe to the location message.
- the radio frequency, electromagnetic 203 guides the autonomous positioning and moving module to guide the internal magnetic device 203 to drive the micro-robot to swim and move to the position of the damaged tissue.
- the in vivo vision device 201 and the disease images of the in vitro imaging device 210 issued by the main control system the double accurate positioning of organs and damaged tissues, and the double accurate identification method. High-precision division of normal areas and damaged areas. Determine the scope of surgery to delineate the damaged area, the scope of the drug delivery location and its coordinates.
- the action planning command message is issued, the robot checks the surgical device, and the robot treatment device subscribes to the command message.
- the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan.
- the robot inspects the surgical device module, imaging in the camera body, and in vitro imaging 210 to guide the device to accurately locate the damaged tissue, and accurately divide the damaged tissue area from the normal tissue area, according to the degree of damage.
- the doctor remotely controls the built-in micro forceps, micro forceps, puncture and retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, laser devices and other surgical devices 204, damaged tissue inspection and operation. Operation to achieve cutting, suturing, puncture, cautery, electrosurgery, laser cutting, targeted therapy.
- Determining drugs and their quantification methods, monitoring the indicators of the body's internal immune environment, and the tumor treatment microenvironment are constant.
- the main treatment drugs, the dosage of common drugs, and the cycle are variables. Establish the mathematical model of the internal immune environment of the body, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and calculate the optimal internal immune environment of the body.
- the model variables are as follows:
- main drug main drug (main drug m m ⁇ 1, 2, ....M ⁇ )
- Monitoring indicators monitor e e ⁇ 1, 2, ....E ⁇ , monitoring real-time indicators monitor e-realtime , monitoring indicator standards monitor e-std
- the number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs and other drugs.
- Constraints include:
- Multi-target includes:
- the body's internal immune environment is optimal,
- the optimal regulation of drugs and doses Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of treatment methods and drug methods, the optimal regulation of drugs and doses, accurate positioning of carcinogenic sites, specific tumor cells, drug delivery, To achieve optimal regulation of treatment. Output the medication and dosage in different time periods.
- plan the amount of radiopharmaceutical (chemotherapy) spraying plan the radiopharmaceutical seeding path, return the drug delivery path and the position coordinates of each seeding point
- the main control system publishes the returned drug delivery path and the position of each seeding point.
- the doctor remotely controls and autonomously controls the drug delivery device, and moves the drug delivery device to each seeding point for drug delivery.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Robotics (AREA)
- Endoscopes (AREA)
- Electrotherapy Devices (AREA)
- Manipulator (AREA)
- Radiation-Therapy Devices (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims (10)
- 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,一种体内微型机器人装置包括:An in-vivo micro-robot device, an optimized treatment regulation system and method, is characterized in that, an in-vivo micro-robot device comprises:主控制系统,所述主控制系统用于控制体内微型机器人装置;a main control system, the main control system is used to control the in vivo micro-robot device;体内微型机器人装置包括:视觉识别模块,多传感模块,照明装置,体内行走驱动装置,穿刺装置,手术检查处理装置,驱动装置,软体支架,固定装置,治疗装置,精准投药装置;The in-vivo micro-robot device includes: a visual recognition module, a multi-sensing module, a lighting device, an in-vivo walking driving device, a puncture device, a surgical inspection processing device, a driving device, a soft support, a fixing device, a treatment device, and a precise drug delivery device;体外成像装置,用于体外成像,包括:超声成像,CT成像,红外近成像,X光成像等多种成像方式中的一种;In vitro imaging device, used for in vitro imaging, including: one of various imaging methods such as ultrasound imaging, CT imaging, infrared near imaging, and X-ray imaging;体内的微型摄像头及视觉识别模块,用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置;The miniature camera and visual recognition module in the body are used to collect in-vivo images, assist in the identification of damaged tissues and tumors in the body, and locate their positions;光,照明装置,用于体内照明,摄像检查;Light, lighting device, used for internal lighting, camera inspection;多传感模块,包括:微型生物传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息;Multi-sensing modules, including: one or more of a variety of sensors such as miniature biosensing, integrated gene sensing, etc., used to collect sensor information in vivo;驱动装置,用于驱动机器人在体内无损伤,可控速,有方向的游动;The driving device is used to drive the robot to swim without damage in the body, with controllable speed and direction;引导,定位,移动装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤。定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置;The guiding, positioning, and moving device is connected with the in vitro imaging device, and the in vitro imaging system guides the in vivo micro-robot to position, move, assist in the acquisition of in-vivo images, assist in identifying the damaged tissue and tumor in the body, and guide the in-vivo micro-robot to locate the damaged tissue and tumor in the body. Positioning and guiding devices include: RF radio frequency devices (external transmitters and in vivo receivers), electromagnetic guiding devices (external electromagnetic controllers and in vivo micro coils and other electromagnetic devices), magnetic guiding devices (external magnetic controllers and in vivo micro coils), etc. Carry out internal and external communication, guide the positioning of the internal robot, and move the device;软体支架,固定装置,用于体内游动,一时停止,破损组织,肿瘤位置手术处理时固定;Soft stent, fixation device, used for swimming in the body, temporary stop, damaged tissue, fixation of tumor location during surgical treatment;可伸缩的体内检查,手术处理装置,包括:微型的镊子,微型钳子,穿刺用刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种。用于体内检查,穿刺,手术操作,消融治疗;Retractable in-vivo inspection and surgical treatment devices, including: one or more of micro forceps, micro forceps, puncture needles, micro electrocautery, micro electrocoagulation device, micro cauterization device, radio frequency device, and laser device. For internal examination, puncture, surgical operation, ablation treatment;可伸缩的治疗,精准投药装置,可伸缩的治疗装置,用于破损组织,药物粒子植入,放置装置,用于放射治疗,放射性粒子植入治疗;可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损组织,肿瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。Retractable treatment, precise drug delivery device, retractable treatment device, used for damaged tissue, drug particle implantation, placement device, used for radiation therapy, radioactive particle implantation therapy; retractable precise drug delivery device, used to locate damage Tissue, tumor location, calculation of damaged tissue, tumor size, degree of damage, precise drug determination, drug delivery device for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cell target drug delivery therapy, radiation therapy, radioactive seed implantation A variety of precise drug delivery treatments such as injection therapy.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,通过口腔,鼻腔,耳道,肚脐,阴道,肛门等器官,体内通过电磁,射频,磁等引导装置移动定位,减少体外手术创伤大风险高,实现基本无创伤,体内检查,手术,高效地实现了体内实时监测,最优化控制体内病情。An in vivo micro-robot device according to claim 1, characterized in that, through the oral cavity, nasal cavity, ear canal, navel, vagina, anus and other organs, the body is moved and positioned by electromagnetic, radio frequency, magnetic and other guiding devices, reducing the need for external surgery The risk of trauma is high and it is basically non-invasive. In-vivo examination and surgery can efficiently realize real-time monitoring in the body and optimize the control of the disease in the body.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,双精准的成像方式,采用微型摄像头的体内摄像头及视觉识别模块与体外成像装置协同作业,高精准采集,辅助识别器官,破损组织,肿瘤等图像,准确识别破损组织及正常组织区域;体内摄像头及视觉识别模块用于采集体内图像,辅助识别体内破损组织,肿瘤,定位其位置;所述的视觉识别模块包括:微型内窥镜,微型显微镜等体内成像装置中的一 种与多种以及3D成像系统与体外成像引导装置协同作业,采集并智能识别体内多种疾病图像。An in-vivo micro-robot device according to claim 1, characterized in that, the dual-precision imaging method adopts the in-vivo camera and the visual recognition module of the micro-camera to cooperate with the in-vitro imaging device, high-precision acquisition, auxiliary identification of organs, damage to Tissue, tumor and other images, accurately identify damaged tissue and normal tissue area; in-vivo camera and visual recognition module are used to collect in-vivo images, assist in identifying damaged tissue, tumor in vivo, and locate their positions; the visual recognition module includes: micro endoscopy One of the in vivo imaging devices such as microscopes, micro microscopes, etc., as well as 3D imaging systems and in vitro imaging guidance devices, work together to collect and intelligently identify images of various diseases in the body.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,驱动装置驱动机器人在体内无损伤,可控速,有方向的游动,利用软体支架,固定装置一时性固定,辅助体内机器人实施手术,破损组织检查等完成体内治疗,利用定位,引导装置,与体外成像装置连接,通过体外成像系统引导体内微型机器人定位,移动,辅助采集体内图像,辅助识别体内破损组织,肿瘤以及引导体内微型机器人定位体内破损组织,肿瘤;体内游动,驱动装置,用于驱动微型机器人体内移动,行走,游动;驱动装置包括:电流驱动,电磁驱动及磁驱动中的一种;定位,引导装置包括:RF射频装置(体外发射器及体内接收器),电磁引导装置(体外电磁控制器及体内微型线圈等电磁装置),磁引导装置(体外磁控制器及体内微型线圈)等进行体内外通信,引导体内机器人定位,移动装置,软体支架,固定装置,用于体内组织检查,破损组织,肿瘤位置的手术处理时的固定。An in-vivo micro-robot device according to claim 1, wherein the driving device drives the robot to move in a non-damaged, speed-controlled, directional way in the body, using a soft support, the fixing device is temporarily fixed, and assists the in-vivo robot Perform surgery, damage tissue inspection, etc. to complete in vivo treatment, use positioning and guiding devices, connect with in vitro imaging devices, guide in vivo micro-robot positioning and movement through the in vitro imaging system, assist in the acquisition of in vivo images, assist in the identification of damaged tissue, tumors in vivo and guide in vivo Micro-robot locates damaged tissues and tumors in the body; in-vivo swimming, driving device is used to drive the micro-robot to move, walk and swim in vivo; the driving device includes: one of current drive, electromagnetic drive and magnetic drive; positioning and guiding device Including: RF radio frequency device (external transmitter and in vivo receiver), electromagnetic guidance device (external electromagnetic controller and in vivo micro coil and other electromagnetic devices), magnetic guidance device (external magnetic controller and in vivo micro coil), etc. for internal and external communication , Guided in vivo robot positioning, mobile device, soft support, fixation device, used for in vivo tissue inspection, damaged tissue, and fixation of tumor location during surgical treatment.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,多传感模块实时监测体内环境,多传感包括:微型生物传感,微型医疗传感,综合的基因传感等多种传感器中的一种及多种,用于采集体内传感器信息,实时监测体内环境;体内体环境包括:体内免疫环境以及肿瘤治疗微环境等治疗,监测期间的体内环境。The in-vivo micro-robot device according to claim 1, wherein the multi-sensing module monitors the in-vivo environment in real time, and the multi-sensing includes: micro bio-sensing, micro-medical sensing, integrated gene sensing, etc. One or more of the sensors are used to collect in vivo sensor information and monitor the in vivo environment in real time; the in vivo in vivo environment includes: the in vivo immune environment and the tumor treatment microenvironment, and the in vivo environment during monitoring.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,体内检查,手术处理装置。手术检查处理装置,包括:微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置中的的一种与多种,用于检查,穿刺,手术操作;通过摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,采用远端操控体内微型机器人装置内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置实现切割,缝合,穿刺,烧灼,激光切割,靶向治疗。An in-vivo micro-robot device according to claim 1, characterized in that it is an in-vivo examination and a surgical treatment device. Surgical inspection and processing devices, including: one or more of micro forceps, micro forceps, puncture retractable needles, micro electrosurgical knives, micro electrocoagulation devices, micro cauterization devices, radio frequency devices, and laser devices, used for inspection, Puncture, surgical operation; the in vivo imaging of the camera and the in vitro imaging guide device are used to precisely locate the damaged tissue, and accurately divide the damaged tissue area and the normal tissue area. Pliers, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device for cutting, suturing, puncturing, cauterization, laser cutting, targeted therapy.
- 根据权利要求1所述的一种体内微型机器人装置,其特征在于,可伸缩的治疗,精准投药装置,粒子植入装置以及依照破损位置,破损区域尺寸,破损程度的药品定量最优化方法,实现精准投药,精准的靶向治疗,准确划分破损的组织区域与正常组织区域实现投药副作用最小,投药效果最优化;可伸缩的精准投药装置,用于定位破损组织,肿瘤的位置,计算破损组织,肿瘤的尺寸,破损程度,精准定药,投药装置,用于精准投药,致癌位点药物投放,特异性肿瘤细胞靶点投药治疗,放射治疗,放射性粒子植入治疗等多种精准投药治疗。An in-vivo micro-robot device according to claim 1, characterized in that, the retractable treatment, precise drug delivery device, particle implantation device, and a quantitative optimization method for drugs according to the damaged position, the size of the damaged area, and the degree of damage, realize Precise drug delivery, precise targeted therapy, accurate division of damaged tissue area and normal tissue area to minimize drug side effects and optimize drug delivery effect; retractable precise drug delivery device, used to locate damaged tissue, tumor location, calculate damaged tissue, The size of the tumor, the degree of damage, the precise drug setting, and the drug delivery device are used for precise drug delivery, drug delivery at carcinogenic sites, specific tumor cell target drug delivery therapy, radiotherapy, radioactive particle implantation therapy and other precise drug delivery treatments.
- 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,器官,破损组织的双精准定位,双精准识别方法,体内视觉装置,体外成像装置双精准识别人体器官,破损组织,划分正常区域及破损区域的高精准识别;An in-vivo micro-robot device, an optimized treatment regulation system and method, characterized in that the dual-precision positioning of organs and damaged tissues, the dual-precision identification method, the in-vivo vision device, and the in-vitro imaging device dual-precision identification of human organs, damaged tissues, division High-precision identification of normal areas and damaged areas;体外的成像装置及人体器官特征位置及医疗图像与显微镜,内窥镜下内部脏器识别方法,包括以下步骤:An in vitro imaging device and a characteristic position of human organs, a medical image and a microscope, and a method for recognizing internal organs under an endoscope, comprising the following steps:S1、建立体外成像图像及体内显微镜下的人体器官的轮廓,形状,纹理,颜色,尺寸等的特征模型;S1. Establish a characteristic model of the contour, shape, texture, color, size, etc. of human organs under in vitro imaging images and in vivo microscopes;S2、建立破损组织炎症,肿瘤,囊肿等多种疾病模型;S2. Establish various disease models such as damaged tissue inflammation, tumor, cyst, etc.;S3、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓,各器官的特征值及其对应的外部特征所对应的人体外部位置区;S3, extracting the in vitro imaging image and the internal contour of the image organ under the in vivo microscope, the feature value of each organ and the external position area of the human body corresponding to the corresponding external feature;S4、输入体外成像图像及体内显微镜下的图像的各器官外部特征值所对应的人体内部器官图像的特征值,改进深度神经网络方法及权值优化器,通过图像训练,得到输出值及内部器官分类,器官识别结果;S4. Input the eigenvalues of the human internal organ images corresponding to the external eigenvalues of each organ of the in vitro imaging image and the image under the in vivo microscope, improve the deep neural network method and the weight optimizer, and obtain the output values and internal organs through image training Classification, organ identification results;S5、输出结果,精准分类,识别体外成像及体内显微镜下的人体器官图像;S5. Output results, accurately classify, and identify human organ images under in vitro imaging and in vivo microscopes;机器人双图像匹配,定位,精准划分破损组织的疾病位置及正常组织的方法,包括以下步骤:The method of robot double image matching, positioning, and accurately dividing the diseased position of damaged tissue and normal tissue, including the following steps:S1、微型机器人发布体内显微镜下图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标;S1. The micro-robot publishes the position area of the organ and its coordinate boundary in the image under the in vivo microscope, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates;S2、体外成像系统模块发布体外成像图像的器官的位置区域及其坐标边界,机器人主系统及智能识别模块订阅其发布图像,位置坐标;S2. The in vitro imaging system module publishes the position area of the organ and its coordinate boundary of the in vitro imaging image, and the robot main system and the intelligent recognition module subscribe to the published image and position coordinates;S3、利用坐标转换方法,建立机器人主控制系统下双图像的坐标参照转换,各器官的双图像下的器官及其坐标位置匹配;S3. Use the coordinate transformation method to establish the coordinate reference transformation of the dual images under the main control system of the robot, and match the organs and their coordinate positions under the dual images of each organ;S4、建立体内显微镜下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型;S4. Establish a model of various diseases such as inflammation, tumor, cyst and other diseases of damaged tissue images under the in vivo microscope;S5、建立体外成像系统下图像破损组织炎症,肿瘤,囊肿等多种疾病的模型;S5. Establish models of various diseases such as inflammation, tumors, cysts and other diseases in damaged tissue images under the in vitro imaging system;S6、抽取体外成像图像及体内显微镜下的的图像器官的内部轮廓及其疾病模型下的特征值及其对应的位置区,位置坐标;S6, extracting the in vitro imaging image and the internal contour of the image organ under the in vivo microscope and the eigenvalues under the disease model and its corresponding position area and position coordinates;S7、利用改进的神经网络方法及权值优化器,识别双系统图像下的疾病,标注并画出双图像下的疾病位置区域,尺寸,返回位置坐标;S7. Use the improved neural network method and weight optimizer to identify the disease under the dual-system image, label and draw the disease location area and size under the dual-image, and return the position coordinates;S8、智能识别模块输出疾病种类,疾病器官及其器官下异常病症的位置区域,返回其识别结果至主控制系统。S8. The intelligent identification module outputs the disease type, the diseased organ and the location area of the abnormal condition under the organ, and returns the identification result to the main control system.
- 一种机器人装置、最优化控制系统、方法,其特征在于,采用最优化的方法调控药物及治疗方法。药物调控包括:药物选择,药物的用量,药物的周期;调控治疗方法包括:体内手术,普通药物精准治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式,设定多种治疗的综合指标为多目标,最优化调控治疗方案;其中,最优化的方法包括:遗传计算方法及其改进方法,禁忌搜索计算方法及其改进方法,模拟退火计算方法及其改进方法,蚁群计算方法及其改进方法,粒子束最优化的计算方法及其改进方法,神经网络计算方法及其改进方法,进化方法及其改进方法,中的一种及多种;通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗,调控的具体步骤如下:A robotic device, an optimal control system, and a method, characterized in that an optimal method is used to regulate medicines and treatment methods. Drug regulation includes: drug selection, drug dosage, and drug cycle; regulatory treatment methods include: internal surgery, precision treatment with common drugs, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy and other treatment methods. The comprehensive index of the treatment is multi-objective, and the optimal regulation and treatment plan; wherein, the optimization methods include: genetic computing method and its improvement method, tabu search calculation method and its improvement method, simulated annealing calculation method and its improvement method, ant One or more of swarm computing method and its improvement method, particle beam optimization calculation method and its improvement method, neural network calculation method and its improvement method, evolutionary method and its improvement method; The combination of real-time dynamic adjustment of treatment methods and drug methods can optimize and control drugs and doses, accurately locate carcinogenic sites, specific tumor cells, and administer drugs to achieve optimal control and treatment. The specific steps of control are as follows:S1.监测的身体内部免疫环境的指标,肿瘤治疗微环境的指标为常量;S1. The indicators of the immune environment within the body to be monitored, and the indicators of the tumor treatment microenvironment are constant;身体内部免疫环境最优---监测指标与标准指标差的绝对值*权值的总和;The optimal immune environment in the body---the absolute value of the difference between the monitoring index and the standard index * the sum of the weights;肿瘤治疗微环境最优-----监测指标与标准指标差的绝对值*权值的总和;The optimal tumor treatment microenvironment—the absolute value of the difference between the monitoring index and the standard index * the sum of the weights;S2.主要的治疗方法(体内手术,普通药物精准治疗,靶点治疗,放射治疗,放射性粒子植入治疗,消融治疗等治疗方式)S2. The main treatment methods (in vivo surgery, precision medicine treatment, targeted therapy, radiation therapy, radioactive seed implantation therapy, ablation therapy, etc.)以及普通药物治疗的药物选择,药物用量,时间周期为变量;As well as drug selection, drug dosage, and time period for common drug therapy are variables;S3.分别建立身体内部免疫环境的数学模型,肿瘤治疗微环境最优数学模型,肿瘤治疗副作用数学模型,药物抵达数学模型如下:S3. Establish the mathematical model of the body's internal immune environment, the optimal mathematical model of the tumor treatment microenvironment, the mathematical model of the side effects of tumor treatment, and the mathematical model of drug arrival as follows:变量:variable:药品的分类:主要治疗药物(main drug m m∈{1,2,....M}) Classification of drugs: main drug (main drug m m∈{1, 2, ....M})普通调解药物(drug nn∈{1,2,....N}) Common Mediation Drug (drug n n∈{1,2,....N})治疗周期(t tt∈{1,2,....T}), treatment period (t t t∈{1, 2, ....T}),疾病(D dd∈{1,2,....D}), disease(D d d∈{1,2,....D}),治疗方法参数Treatment method parameters包括主要的治疗方法(硬性治疗指标 )及普通药物治疗方法 Including the main treatment method (hard treatment index ) and common drug treatments监测指标monitor ee∈{1,2,....E},监测实时指标monitor e-realtime,监测指标标准monitor e-std Monitoring indicators monitor e e∈{1, 2, ....E}, monitoring real-time indicators monitor e-realtime , monitoring indicator standards monitor e-std副作用监测指标monitor sub-bb∈{1,2,....B}; Side effect monitoring indicator monitor sub-b b∈{1, 2, ....B};●身体内部免疫环境最优:●The optimal immune environment in the body:●肿瘤治疗微环境最优:Optimal tumor treatment microenvironment:●肿瘤治疗副作用最小:●Minimum side effects of tumor treatment:●药物抵达最优:●The drug arrives optimally:规划的施药数量多为放射药物,靶向药物,化疗药物等的药物;The number of planned drugs is mostly radiopharmaceuticals, targeted drugs, chemotherapy drugs, etc.;●治疗周期最短:●Shortest treatment cycle:S4.制约条件包括:S4. Constraints include:1)时间周期内的药物最大用量上限范围内1) Within the upper limit of the maximum dosage of the drug within the time period2)药物最长使用周期范围内2) Within the longest period of use of the drug3)用药周期标准值范围内3) Within the range of the standard value of the medication cycle4)破损组织的区域范围内4) Within the area of damaged tissue5)治疗期内的最大副作用的承受能力范围内5) Within the tolerance range of the maximum side effects during the treatment period6)满足疾病的基本用药治疗疗效6) Satisfy the efficacy of the basic drug treatment for the disease7)满足药物的基本用量7) Meet the basic dosage of the drugS5.多目标包括:S5. Multi-target includes:身体内部免疫环境最优,The body's internal immune environment is optimal,肿瘤治疗微环境最优,The optimal tumor treatment microenvironment,治疗副作用最小,Treatment with minimal side effects,药物抵达最优,The drug arrives at the best,治疗周期最短,The shortest treatment period,MIN(F)MIN(F)S6.通过最优化方法中的一种及多种,通过静态治疗效果预测及实时动态调整治疗方法药物方法相结合,最优化调控药物,药量,精准定位致癌位点,特异性肿瘤细胞,投放药物,实现最优化调控治疗;S6. Through one or more of the optimization methods, through the combination of static treatment effect prediction and real-time dynamic adjustment of the treatment method and drug method, the drug is optimally regulated, the amount of the drug, the precise positioning of the carcinogenic site, the specific tumor cell, and the delivery. Drugs to achieve optimal regulation and treatment;S7.输出不同时间周期内的用药及用药量。S7. Output the medication and the amount of medication in different time periods.
- 一种体内微型机器人装置,最优化治疗调控系统及方法,其特征在于,一种高精准定位,远端控制的无创体内手术方法以及远端及自主的投药方法,所述方法包括以下步骤:An in-vivo micro-robot device, an optimized treatment regulation system and method, characterized in that a non-invasive in-vivo surgical method with high-precision positioning and remote control, and a remote and autonomous drug administration method, the method comprises the following steps:S1、主控制系统发布疾病图像,破损组织的位置消息;S1. The main control system publishes disease images and location information of damaged tissues;S2、机器人驱动模块,射频接收器或电磁引导自主定位移动模块订阅位置消息;S2. The robot drive module, the radio frequency receiver or the electromagnetic guided autonomous positioning mobile module subscribes to the location message;S3、射频接收器或电磁引导磁引导自主定位移动模块引导体内磁装置驱动微型机器人游动,移动至破损组织的位置;S3. The radio frequency receiver or the electromagnetic guided magnetic guided autonomous positioning and moving module guides the internal magnetic device to drive the micro-robot to swim and move to the position of the damaged tissue;S4、依据主控制系统发布的体内视觉装置,体外成像装置的疾病图像,依据权利要求7所述的器官,破损组织的双精准定位,双精准识别方法,高精准划分正常区域及破损区域;S4. According to the in-vivo vision device and the disease image of the in-vitro imaging device released by the main control system, according to the organ according to claim 7, double-precision positioning of damaged tissue, double-precision identification method, high-precision division of normal area and damaged area;S5、确定划定破损区域的手术范围,投药位置范围及其坐标;S5. Determine the scope of surgery to delineate the damaged area, the scope of the drug administration position and its coordinates;S6、依据主控制系统发布动作规划指令消息,机器人检查手术装置,机器人治疗装置订阅指令消息。S6. According to the main control system, the action planning instruction message is released, the robot checks the surgical device, and the robot treatment device subscribes to the instruction message.进一步,所述动作规划模块,包括机器人检查手术动作规划,机器人治疗投药动作规划;Further, the action planning module includes a robot inspection operation action plan, and a robot treatment drug administration action plan;S7、步骤S6中,所述的机器人检查手术装置模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度,医生远端操控体内微型机器人内置的微型的镊子,微型钳子,穿刺可伸缩刺针,微型电刀,微型电凝装置,微型烧灼装置,射频装置,激光装置等手术装置,破损组织检查及执行手术操作,实现切割,缝合,穿刺,烧灼,电刀,激光切割,靶向治疗;S7. In step S6, the robot inspects the surgical device module, images in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, accurately divides the damaged tissue area and the normal tissue area, and according to the degree of damage, the doctor remotely controls the body Micro-robot built-in micro forceps, micro forceps, puncture retractable needle, micro electrocautery, micro electrocoagulation device, micro cautery device, radio frequency device, laser device and other surgical devices, damaged tissue inspection and performing surgical operations, realize cutting, suturing , puncture, cautery, electrosurgery, laser cutting, targeted therapy;S8、步骤S6中,所述的机器人治疗投药动作规划模块,在摄像头体内成像,及体外成像引导装置精确定位破损组织,准确划分破损的组织区域与正常组织区域,依据破损程度;S8. In step S6, the robot treatment and drug administration action planning module is used for imaging in the camera body, and the in vitro imaging guide device accurately locates the damaged tissue, and accurately divides the damaged tissue area and the normal tissue area, according to the degree of damage;S9、利用权利要求9所述的治疗综合指标多目标最优化调控方法,规划放射药物(化疗药物)施药的数量,规划放射药物播种路径,返回投药路径以及各播种点位置坐标;S9, using the multi-objective optimization control method for comprehensive treatment indicators according to claim 9, planning the quantity of radiopharmaceuticals (chemotherapeutic drugs) sprayed, planning the radiopharmaceutical seeding path, returning the drug delivery path and the position coordinates of each seeding point;S10、主控制系统发布按照返回的投药路径以及各播种点位置坐标,医生远端操控以及自主控制投药。S10, the main control system issues the doctor's remote control and autonomous control of the drug administration according to the returned drug administration path and the position coordinates of each seeding point.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2022252507A AU2022252507A1 (en) | 2021-03-29 | 2022-03-18 | Miniature in-vivo robot device, and optimal treatment regulation and control system and method |
CN202280024177.8A CN117545443A (en) | 2021-03-29 | 2022-03-18 | In-vivo micro-robot device, and optimized treatment regulation and control system and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110343943.4 | 2021-03-29 | ||
CN202110343943.4A CN113100690A (en) | 2021-03-29 | 2021-03-29 | In-vivo micro-robot device, and optimized treatment regulation and control system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022206083A1 true WO2022206083A1 (en) | 2022-10-06 |
Family
ID=76712986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/000044 WO2022206083A1 (en) | 2021-03-29 | 2022-03-18 | Miniature in-vivo robot device, and optimal treatment regulation and control system and method |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN113100690A (en) |
AU (1) | AU2022252507A1 (en) |
WO (1) | WO2022206083A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113100690A (en) * | 2021-03-29 | 2021-07-13 | 谈斯聪 | In-vivo micro-robot device, and optimized treatment regulation and control system and method |
TWI829095B (en) * | 2022-02-15 | 2024-01-11 | 國立成功大學 | Microrobot and manufacturing method thereof |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050029978A1 (en) * | 2003-07-08 | 2005-02-10 | Dmitry Oleynikov | Microrobot for surgical applications |
US20060119304A1 (en) * | 2003-07-08 | 2006-06-08 | Shane Farritor | Robot for surgical applications |
CN101351141A (en) * | 2005-12-27 | 2009-01-21 | 奥林巴斯株式会社 | Encapsulated medical device guiding system and its control method |
CN202136314U (en) * | 2011-07-21 | 2012-02-08 | 长沙学院 | Human intracavity tiny canal-oriented microrobot |
US20130282173A1 (en) * | 2012-04-20 | 2013-10-24 | Erhan H. Gunday | Remotely Controlled Surgical Robots |
CN103405209A (en) * | 2013-07-17 | 2013-11-27 | 南京航空航天大学 | Intra-individual peristaltic detection and treatment all-in-one robot |
US20160346048A1 (en) * | 2011-03-22 | 2016-12-01 | Corindus, Inc. | Robotic catheter system including imaging system control |
CN108837286A (en) * | 2018-05-04 | 2018-11-20 | 清华大学 | Degradable diagnosis and treatment robot |
CN109419557A (en) * | 2017-08-27 | 2019-03-05 | 南京乐朋电子科技有限公司 | A kind of microrobot for interior therapeutic |
CN113100690A (en) * | 2021-03-29 | 2021-07-13 | 谈斯聪 | In-vivo micro-robot device, and optimized treatment regulation and control system and method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11324451B2 (en) * | 2017-06-26 | 2022-05-10 | Bruce Reiner | Nanobots with embedded biosensors |
WO2018144636A1 (en) * | 2017-02-01 | 2018-08-09 | Intuitive Surgical Operations, Inc. | Systems and methods of registration for image-guided procedures |
-
2021
- 2021-03-29 CN CN202110343943.4A patent/CN113100690A/en active Pending
-
2022
- 2022-03-18 WO PCT/CN2022/000044 patent/WO2022206083A1/en active Application Filing
- 2022-03-18 CN CN202280024177.8A patent/CN117545443A/en active Pending
- 2022-03-18 AU AU2022252507A patent/AU2022252507A1/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050029978A1 (en) * | 2003-07-08 | 2005-02-10 | Dmitry Oleynikov | Microrobot for surgical applications |
US20060119304A1 (en) * | 2003-07-08 | 2006-06-08 | Shane Farritor | Robot for surgical applications |
CN101351141A (en) * | 2005-12-27 | 2009-01-21 | 奥林巴斯株式会社 | Encapsulated medical device guiding system and its control method |
US20160346048A1 (en) * | 2011-03-22 | 2016-12-01 | Corindus, Inc. | Robotic catheter system including imaging system control |
CN202136314U (en) * | 2011-07-21 | 2012-02-08 | 长沙学院 | Human intracavity tiny canal-oriented microrobot |
US20130282173A1 (en) * | 2012-04-20 | 2013-10-24 | Erhan H. Gunday | Remotely Controlled Surgical Robots |
CN103405209A (en) * | 2013-07-17 | 2013-11-27 | 南京航空航天大学 | Intra-individual peristaltic detection and treatment all-in-one robot |
CN109419557A (en) * | 2017-08-27 | 2019-03-05 | 南京乐朋电子科技有限公司 | A kind of microrobot for interior therapeutic |
CN108837286A (en) * | 2018-05-04 | 2018-11-20 | 清华大学 | Degradable diagnosis and treatment robot |
CN113100690A (en) * | 2021-03-29 | 2021-07-13 | 谈斯聪 | In-vivo micro-robot device, and optimized treatment regulation and control system and method |
Also Published As
Publication number | Publication date |
---|---|
CN117545443A (en) | 2024-02-09 |
AU2022252507A1 (en) | 2023-11-16 |
CN113100690A (en) | 2021-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022206083A1 (en) | Miniature in-vivo robot device, and optimal treatment regulation and control system and method | |
US11571258B2 (en) | Path planning method with artificial potential field based on obstacle classification and medical system for steering flexible needle | |
EP1396233B1 (en) | Positioning system for neurological procedures in the brain | |
CN102319117B (en) | Arterial intervention implant implanting system capable of fusing real-time ultrasonic information based on magnetic navigation | |
US20100268072A1 (en) | Method and apparatus for positional tracking of therapeutic ultrasound transducer | |
JP2021502195A (en) | Robotic equipment for minimally invasive medical interventions in soft tissues | |
US20120281898A1 (en) | Method of identification of an element in two or more images | |
CN107847278A (en) | Optics targets and track visualization | |
CN109077801B (en) | Diagnosis and treatment method and system for multi-source information guided laser ablation | |
CN110327016A (en) | Intelligent minimally invasive diagnosis and treatment integral system based on optical image and optical therapeutic | |
CN112022348A (en) | Puncture ablation intraoperative navigation system under CT and AI dual guidance | |
Kaur | How Medical Robots are going to Affect Our Lives: Pushing frontiers with the first lady of emerging technologies | |
Yin et al. | Open thoracic surgical implantation of cardiac pacemakers in rats | |
WO2022133054A1 (en) | Tissue interface system | |
CN105435378A (en) | Focusing ultrasonic treatment system | |
CN109011222A (en) | Body surface positioning guide plate for guiding radioactive particles to perform brachytherapy on cancer and manufacturing method | |
Narula et al. | Future prospects of artificial intelligence in robotics software, a healthcare perspective | |
CN110464456B (en) | Automatic laser treatment robot | |
WO2022199198A1 (en) | Intravascular nano robot apparatus, optimized control system, and method | |
Ibrahim et al. | Robot-assisted for medical surgery: A literature review | |
Garg et al. | Equipment planning | |
CN116712163B (en) | Robot system for performing radio frequency ablation operation | |
CN209490085U (en) | Apparats for treating tumor | |
CN219021459U (en) | Interventional needle and interventional system | |
Shaikh | Robotic Imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22778272 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023550256 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280024177.8 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022252507 Country of ref document: AU Ref document number: AU2022252507 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022778272 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022778272 Country of ref document: EP Effective date: 20231030 |
|
ENP | Entry into the national phase |
Ref document number: 2022252507 Country of ref document: AU Date of ref document: 20220318 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 01/03/2024) |